Press release
Lupus Market Share Grows at a CAGR of 11.2% to 2023: Latest Developments Comprehensive Analysis and Research Report 2019
Lupus Market
Market Outlook
Global Lupus Market is anticipated to have held a market value of USD 1.48 billion in the year 2017 and is expected to grow at a CAGR of 11.2% during the forecast period.
Lupus is an autoimmune disease in which the immune system produces antibodies that attack the body’s healthy tissue. The antibodies produced by the immune system in lupus cause inflammation, tissue damage, and pain. Majority of the patients affected by lupus are women, and the majority of the people develop lupus between 15 to 45 years of age.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/6636
Key Players
Some of the prominent players in the global lupus market are Aurinia Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Cadila Healthcare, GlaxoSmithKline plc, Mylan N.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Sanofi, Lycera Corporation, Eli Lily and Company, and Merck KGaA.
Market Segmentation:
The Global Lupus Market has been segmented into type, treatment, and end user. The global market, by types, has been segmented into systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, and neonatal lupus. The systemic lupus erythematosus segment is expected to hold the largest market share owing to the growing prevalence and increasing drug development in recent years.
On the basis of treatment, the global market has been segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, corticosteroids, immunosuppressants, biologics, and other.
On the basis of end user, the global market has been segmented into hospital & clinics, diagnostic laboratories, and others.
Global Lupus Market, by Technique
Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus
Drug-Induced Lupus Erythematosus
Neonatal Lupus
Global Lupus Market, by Product
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Antimalarial Drugs
Corticosteroids
Immunosuppressants
Biologics
Others
Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/lupus-market-6636
Market by Regional Analysis
Geographically, the Americas is expected to dominate the global market owing to the presence of well-developed healthcare sector, rising demand for better treatment options, growing prevalence of lupus, government initiatives for lupus, and availability of reimbursement.
Europe is expected to hold the second largest position in the global lupus market owing to the increasing number of research and development activities and the rising prevalence of lupus in the region.
Asia-Pacific region is anticipated to be the fastest growing region owing to the growing prevalence of lupus, continuously growing healthcare sector and increasing regional expansion by prominent market players. The Middle East & Africa has the lowest share of the market.
Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector.
Intended Audience
Research and consulting firmsPharmaceutical and biotechnology manufacturers
Contract research organizations (CROs)
Contract manufacturing organizations (CMOs)
Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6636
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Market Share Grows at a CAGR of 11.2% to 2023: Latest Developments Comprehensive Analysis and Research Report 2019 here
News-ID: 1606780 • Views: …
More Releases from Market Research Future
Salicylic Acid Market Analysis: Industry Growth at a 7.0% CAGR During 2026-2035
The global salicylic acid market is experiencing robust growth, driven by its essential role in dermatology, cosmetics, and pharmaceutical applications. According to a comprehensive report by Market Research Future, the market was valued at USD 130.12 million in 2025 and is projected to reach USD 254.83 million by 2035, advancing at a compound annual growth rate of 7.0%. This expansion reflects the compound's established regulatory status, increasing consumer demand for…
Specialty Silica Market Set for Steady Growth, Surpassing USD 8,893 Million by 2 …
The global specialty silica market is experiencing steady growth, driven by its indispensable role in high-performance applications ranging from green tires to semiconductor manufacturing. According to a comprehensive report by Market Research Future, the market was valued at USD 5,920 million in 2025 and is projected to reach USD 8,893 million by 2035, advancing at a compound annual growth rate of 4.15%. This trajectory reflects a structural shift in industrial…
Lubricant Additives Market Outlook: Capitalising on High-Performance Formulation …
The global lubricant additives market is navigating a period of profound transformation, driven by tightening emissions regulations, the rise of electric vehicles, and a relentless push for greater fuel efficiency. According to a comprehensive report by Market Research Future, the market was valued at USD 19.55 billion in 2025 and is projected to reach USD 27.71 billion by 2035, advancing at a compound annual growth rate of 3.55%. This growth…
Emulsion Polymers Market: Navigating the Shift Toward Sustainable, High-Performa …
The global emulsion polymers market is on a steady growth trajectory, driven by a powerful combination of environmental regulations, technological innovation, and large-scale infrastructure investment. According to a comprehensive report by Market Research Future, the market was valued at USD 31.15 billion in 2025 and is projected to reach USD 54.98 billion by 2035, reflecting a compound annual growth rate of 5.85%. This expansion is primarily fueled by the accelerating…
More Releases for Lupus
Lupus Nephritis Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the …
DelveInsight's Lupus Nephritis Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline Lupus Nephritis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Lupus Nephritis pipeline domain.
Key takeaways from the Lupus Nephritis Clinical Trial Landscape Report
• DelveInsight's Lupus Nephritis pipeline report depicts a robust space with 25+ active players working to develop 40+…
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
